National and Regional US Antibiotic Resistance to Helicobacter pylori: Lessons From a Clinical Trial

Gastroenterology. 2021 Jul;161(1):342-344.e1. doi: 10.1053/j.gastro.2021.03.045. Epub 2021 Mar 31.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Double-Blind Method
  • Drug Resistance, Bacterial*
  • Female
  • Helicobacter Infections / diagnosis
  • Helicobacter Infections / drug therapy*
  • Helicobacter Infections / microbiology
  • Helicobacter pylori / drug effects*
  • Helicobacter pylori / pathogenicity
  • Humans
  • Male
  • Middle Aged
  • United States
  • Young Adult

Substances

  • Anti-Bacterial Agents